KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Guardant Health (GH) Receivables - Net (2017 - 2025)

Guardant Health's Receivables - Net history spans 9 years, with the latest figure at $137.8 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 25.03% year-over-year to $137.8 million; the TTM value through Dec 2025 reached $137.8 million, up 25.03%, while the annual FY2025 figure was $137.8 million, 25.03% up from the prior year.
  • Receivables - Net for Q4 2025 was $137.8 million at Guardant Health, up from $115.6 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $137.8 million in Q4 2025 and bottomed at $48.0 million in Q1 2021.
  • The 5-year median for Receivables - Net is $88.8 million (2023), against an average of $92.9 million.
  • The largest annual shift saw Receivables - Net skyrocketed 83.22% in 2021 before it fell 9.24% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $97.7 million in 2021, then dropped by 0.41% to $97.3 million in 2022, then dropped by 8.71% to $88.8 million in 2023, then grew by 24.18% to $110.3 million in 2024, then rose by 25.03% to $137.8 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Receivables - Net are $137.8 million (Q4 2025), $115.6 million (Q3 2025), and $130.3 million (Q2 2025).